A recent study has demonstrated a key role for IL-10R signalling in DC in controlling aberrant Th1 responses both via inhibition of IL-1β and IL-12 in paediatric IBD and in an individual with IL10RA gene deficiency [70]. The gene discussed is IL10RA; the disease is inflammatory bowel disease.